srijeda, 22. veljače 2017.

JAK Inhibitors Are New Category of Drugs for Rheumatoid Arthritis

Verywell
JAK Inhibitors Are New Category of Drugs for Rheumatoid Arthritis
How are JAK inhibitors different from biologic drugs? Here's one difference: one works intracellularly while the other has extracellular targets.
READ NOW 
READ THESE NEXT
Xeljanz Was First JAK Inhibitor Approved in 2012 MORE
JAK Inhibitor May Be Combined With Methotrexate MORE
The 5 Main Drug Classes Used to Treat Arthritis MORE
Verywell
AN ABOUT.COM BRAND
You are receiving this newsletter because you subscribed to the Real Life with Arthritis newsletter.
If you wish to unsubscribe, please click here
1500 Broadway, 6th Floor, New York, NY, 10036
© 2017 Verywell.com - All rights reserved. Privacy Policy.
                                                           

Nema komentara:

Objavi komentar